Using MultiOmyx™ to Analyze Correlations between Immunosuppressive Cells and Tumor-Infiltrating Lymphocytes in the Pancreatic Tumor Microenvironment Read more about Using MultiOmyx™ to Analyze Correlations between Immunosuppressive Cells and Tumor-Infiltrating Lymphocytes in the Pancreatic Tumor Microenvironment
Using a Multiplexed Immunofluorescence Assay to Detect Immunosuppressive Cells and their Mechanisms in the Pancreatic Tumor Microenvironment Read more about Using a Multiplexed Immunofluorescence Assay to Detect Immunosuppressive Cells and their Mechanisms in the Pancreatic Tumor Microenvironment
Characterization of Myeloid-Derived Suppressor Cells and Tumor Associated Macrophages Using MultiOmyx™ Hyperplexed Immuno-Assay in Hodgkin Lymphoma Read more about Characterization of Myeloid-Derived Suppressor Cells and Tumor Associated Macrophages Using MultiOmyx™ Hyperplexed Immuno-Assay in Hodgkin Lymphoma
Pro-Tumorigenic Mechanisms of M2 Tumor-Associated Macrophages in Triple-Negative Breast Cancer Read more about Pro-Tumorigenic Mechanisms of M2 Tumor-Associated Macrophages in Triple-Negative Breast Cancer
Characterization of TIGIT Expression Using MultiOmyx™ Hyperplexed Immunofluorescence Assay in NSCLC and melanoma Read more about Characterization of TIGIT Expression Using MultiOmyx™ Hyperplexed Immunofluorescence Assay in NSCLC and melanoma
Using a Multiplexed Immunofluorescence Approach to Compare Immune Cell Populations in Subtypes on Non-Small Cell Lung Cancer Read more about Using a Multiplexed Immunofluorescence Approach to Compare Immune Cell Populations in Subtypes on Non-Small Cell Lung Cancer
An Integrated Multiplexing Approach for the Immunoprofiling of the Tumor Microenvironment of Ovarian Granulosa Cell Tumors Read more about An Integrated Multiplexing Approach for the Immunoprofiling of the Tumor Microenvironment of Ovarian Granulosa Cell Tumors
An Integrated Multiplexing Approach Identifies IDO1 as a Biomarker for Recurrence of Rare Ovarian Granulosa Cell Tumors Read more about An Integrated Multiplexing Approach Identifies IDO1 as a Biomarker for Recurrence of Rare Ovarian Granulosa Cell Tumors
A large study of PIK3CA mutations in the community setting identifies varying degree of mutation positivity rates across age groups in advanced HR+, HER2- breast cancer patients using and FDA TR-PCR cleared test3 Read more about A large study of PIK3CA mutations in the community setting identifies varying degree of mutation positivity rates across age groups in advanced HR+, HER2- breast cancer patients using and FDA TR-PCR cleared test3
Phenotypic Characterization of the Immune Landscape in the Bone Marrow of Patients with Acute Myeloid Leukemia (AML) Using MultiOmyx™ Hyperplexed Immunofluorescence Assay Read more about Phenotypic Characterization of the Immune Landscape in the Bone Marrow of Patients with Acute Myeloid Leukemia (AML) Using MultiOmyx™ Hyperplexed Immunofluorescence Assay